buthionine sulfoximine and glutathione depletion

buthionine sulfoximine and glutathione depletion Permeability-response to (BSO), an agent which Glutathione Depletion and Stalwart Anticancer

Name: buthionine sulfoximine and glutathione depletion Permeability-response to (BSO), an agent which Glutathione Depletion and Stalwart Anticancer
Brand: condeoeiras.edu.pt
SKU: 56815768269
Price: 24.94 USD
Availability: InStock
Rating: 4.234 (16 reviews)

Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor 2 Expressing Pre Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu DOTATATE L Buthionine sulfoximine = 97 TLC 83730 53 4 Glutathione depletion induces oxidative injury and apoptosis via TRPM2 channel activation in renal collecting duct cells ScienceDirect Lowering glutathione level by buthionine sulfoximine enhances in vivo photodynamic therapy using chlorin e6 loaded nanoparticles ScienceDirect Oncology Letters

SKU: 56815768269 · From condeoeiras.edu.pt

4.2

USD24.94 USD68.94

Pay in 4 interest-free payments of $6.24 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Future studies are needed to reconcile the underlying differences between tumor tissue and basal PTC cell line GPX4 expression levels and in vitro responses to pharmacologic inhibition of GPX4 within an emulated 3D thyroid tumor microenvironment in vitro and in vivo